Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia.

Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW.

Clin Lymphoma Myeloma Leuk. 2018 Jul 4. pii: S2152-2650(18)30425-7. doi: 10.1016/j.clml.2018.06.031. [Epub ahead of print]

PMID:
30082224
2.

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.

Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY.

Eur J Nucl Med Mol Imaging. 2018 Jul 28. doi: 10.1007/s00259-018-4093-1. [Epub ahead of print]

PMID:
30056546
3.

Low-Yellowing Phosphor-in-Glass for High-Power Chip-on-board White LEDs by Optimizing a Low-Melting Sn-P-F-O Glass Matrix.

Yoon HC, Yoshihiro K, Yoo H, Lee SW, Oh JH, Do YR.

Sci Rep. 2018 May 9;8(1):7412. doi: 10.1038/s41598-018-25680-6.

4.

Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.

Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH.

Support Care Cancer. 2018 Apr 22. doi: 10.1007/s00520-018-4209-y. [Epub ahead of print]

PMID:
29682690
5.

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.

Hong JY, Yoon DH, Suh C, Kim WS, Kim SJ, Jo JC, Kim JS, Lee WS, Oh SY, Park Y, Kim SY, Lee MH, Lee HS, Do YR.

Ann Hematol. 2018 Aug;97(8):1437-1443. doi: 10.1007/s00277-018-3317-6. Epub 2018 Apr 4.

PMID:
29619501
6.

Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.

Noh H, Jung SY, Kwak JY, Kim SH, Oh SJ, Zang DY, Lee S, Park HL, Jo DJ, Shin JS, Do YR, Kim DW, Lee JI.

Cancer Med. 2018 May;7(5):1766-1773. doi: 10.1002/cam4.1436. Epub 2018 Mar 25.

7.

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.

Shin J, Koh Y, Yoon SH, Cho JY, Kim DY, Lee KH, Kim HJ, Ahn JS, Kim YK, Park J, Sohn SK, Moon JH, Lee YJ, Yoon S, Lee JO, Cheong JW, Kim KH, Kim SH, Kim HG, Kim H, Nam SH, Do YR, Park SG, Park SK, Bae SH, Song HH, Shin DY, Oh D, Kim MK, Jung CW, Park S, Kim I.

Cancer Med. 2018 May;7(5):1814-1823. doi: 10.1002/cam4.1450. Epub 2018 Mar 25.

8.

Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.

Yoo SH, Kim M, Yun YH, Keam B, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Kim SY, Kang EJ, Do YR, Choi YS, Jung KH.

Cancer Med. 2018 May;7(5):1784-1793. doi: 10.1002/cam4.1441. Epub 2018 Mar 25.

9.

Efficient and Stable CsPbBr3 Quantum-Dot Powders Passivated and Encapsulated with a Mixed Silicon Nitride and Silicon Oxide Inorganic Polymer Matrix.

Yoon HC, Lee S, Song JK, Yang H, Do YR.

ACS Appl Mater Interfaces. 2018 Apr 11;10(14):11756-11767. doi: 10.1021/acsami.8b01014. Epub 2018 Mar 30.

PMID:
29566326
10.

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.

Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Lee HS, Yun HJ, Lee SI, Kim MK, Yi JH, Lee JH, Kim WS, Suh C.

Oncotarget. 2017 Sep 18;8(54):92171-92182. doi: 10.18632/oncotarget.20988. eCollection 2017 Nov 3.

11.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
12.

Enhanced DC-Operated Electroluminescence of Forwardly Aligned   p/MQW/n InGaN Nanorod LEDs via DC Offset-AC Dielectrophoresis.

Eo YJ, Yoo GY, Kang H, Lee YK, Kim CS, Oh JH, Lee KN, Kim W, Do YR.

ACS Appl Mater Interfaces. 2017 Nov 1;9(43):37912-37920. doi: 10.1021/acsami.7b09794. Epub 2017 Oct 19.

PMID:
29019239
13.

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.

Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, Kim DY, Park J, Jung CW, Bunworasate U, Comia NS, Jootar S, Reksodiputro AH, Caguioa PB, Lee SE, Kim DW.

Clin Cancer Res. 2017 Dec 1;23(23):7180-7188. doi: 10.1158/1078-0432.CCR-17-0957. Epub 2017 Sep 22.

PMID:
28939746
14.

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

Cho H, Yoon DH, Lee JB, Kim SY, Moon JH, Do YR, Lee JH, Park Y, Lee HS, Eom HS, Shin HJ, Min CK, Kim JS, Jo JC, Kang HJ, Mun YC, Lee WS, Lee JJ, Suh C, Kim K; and the Korean Multiple Myeloma Working Party.

Am J Hematol. 2017 Dec;92(12):1280-1286. doi: 10.1002/ajh.24891. Epub 2017 Sep 8.

PMID:
28833417
15.

Origin of highly efficient photoluminescence in AgIn5S8 nanoparticles.

Han NS, Yoon HC, Jeong S, Oh JH, Park SM, Do YR, Song JK.

Nanoscale. 2017 Jul 27;9(29):10285-10291. doi: 10.1039/c7nr02380d.

PMID:
28696455
16.

Circadian-tunable Perovskite Quantum Dot-based Down-Converted Multi-Package White LED with a Color Fidelity Index over 90.

Yoon HC, Oh JH, Lee S, Park JB, Do YR.

Sci Rep. 2017 Jun 5;7(1):2808. doi: 10.1038/s41598-017-03063-7.

17.

Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.

Ha JS, Do YR, Ki CS, Lee C, Kim DH, Lee W, Ryoo NH, Jeon DS.

Leukemia. 2017 Sep;31(9):1992-1995. doi: 10.1038/leu.2017.167. Epub 2017 May 30. No abstract available.

PMID:
28555082
18.

Multiple-Color-Generating Cu(In,Ga)(S,Se)2 Thin-Film Solar Cells via Dichroic Film Incorporation for Power-Generating Window Applications.

Yoo GY, Jeong JS, Lee S, Lee Y, Yoon HC, Chu VB, Park GS, Hwang YJ, Kim W, Min BK, Do YR.

ACS Appl Mater Interfaces. 2017 May 3;9(17):14817-14826. doi: 10.1021/acsami.7b01416. Epub 2017 Apr 20.

PMID:
28406026
19.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.

Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY.

Oncotarget. 2017 Jun 6;8(23):37605-37618. doi: 10.18632/oncotarget.16790.

20.

Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer.

Kim JY, Do YR, Song HS, Cho YY, Ryoo HM, Bae SH, Kim JG, Chae YS, Kang BW, Baek JH, Kim MK, Lee KH, Park K.

Anticancer Res. 2017 Mar;37(3):1467-1473.

PMID:
28314319
21.

Sequential strategy for umbilical cord blood transplantation in a Korean Fanconi anemia girl with refractory acute myelomonocytic leukemia and complex karyotype.

Shim YJ, Kim HS, Do YR, Ha JS, Yabe H.

Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12871. Epub 2016 Dec 15. No abstract available.

PMID:
27976485
22.

Cycles of circadian illuminance are sufficient to entrain and maintain circadian locomotor rhythms in Drosophila.

Cho E, Oh JH, Lee E, Do YR, Kim EY.

Sci Rep. 2016 Nov 24;6:37784. doi: 10.1038/srep37784.

23.

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.

Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Kim YS, Yun HJ, Lee SI, Kim MK, Park EK, Kim WS, Suh C.

Oncotarget. 2016 Nov 1;7(44):72033-72043. doi: 10.18632/oncotarget.12459.

24.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH.

Leuk Res. 2016 Oct;49:80-7. doi: 10.1016/j.leukres.2016.08.015. Epub 2016 Aug 31.

PMID:
27608179
25.

High-efficiency red electroluminescent device based on multishelled InP quantum dots.

Jo JH, Kim JH, Lee KH, Han CY, Jang EP, Do YR, Yang H.

Opt Lett. 2016 Sep 1;41(17):3984-7. doi: 10.1364/OL.41.003984.

PMID:
27607953
26.

Study of Perovskite QD Down-Converted LEDs and Six-Color White LEDs for Future Displays with Excellent Color Performance.

Yoon HC, Kang H, Lee S, Oh JH, Yang H, Do YR.

ACS Appl Mater Interfaces. 2016 Jul 20;8(28):18189-200. doi: 10.1021/acsami.6b05468. Epub 2016 Jul 7.

PMID:
27349270
27.

Horizontally assembled green InGaN nanorod LEDs: scalable polarized surface emitting LEDs using electric-field assisted assembly.

Park HK, Yoon SW, Eo YJ, Chung WW, Yoo GY, Oh JH, Lee KN, Kim W, Do YR.

Sci Rep. 2016 Jun 21;6:28312. doi: 10.1038/srep28312.

28.

Tunable White Fluorescent Copper Gallium Sulfide Quantum Dots Enabled by Mn Doping.

Jo DY, Kim D, Kim JH, Chae H, Seo HJ, Do YR, Yang H.

ACS Appl Mater Interfaces. 2016 May 18;8(19):12291-7. doi: 10.1021/acsami.6b01763. Epub 2016 May 5.

PMID:
27120773
29.

The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea.

Lee HS, Min CK, Lee JJ, Kim K, Kim SJ, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC, Lee MH; Korean Multiple Myeloma Working Party (KMMWP).

Ann Hematol. 2016 May;95(6):911-9. doi: 10.1007/s00277-016-2660-8. Epub 2016 Apr 6.

PMID:
27052989
30.

Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.

Kong BS, Im SJ, Lee YJ, Cho YH, Do YR, Byun JW, Ku CR, Lee EJ.

PLoS One. 2016 Mar 22;11(3):e0149394. doi: 10.1371/journal.pone.0149394. eCollection 2016.

31.

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study.

Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, Kim HJ, Kim SH, Zang DY, Oh S, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Lee WS, Chang MH, Park J, Kwon JH, Kim DW.

Haematologica. 2016 Jun;101(6):717-23. doi: 10.3324/haematol.2015.139899. Epub 2016 Feb 17.

32.

A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.

Kim SJ, Shin DY, Kim JS, Yoon DH, Lee WS, Lee H, Do YR, Kang HJ, Eom HS, Ko YH, Lee SH, Yoo HY, Hong M, Suh C, Kim WS.

Ann Oncol. 2016 Apr;27(4):712-8. doi: 10.1093/annonc/mdv624. Epub 2016 Feb 8.

PMID:
26861608
33.

Clinical Features and Survival of Patients With Follicular Lymphoma in Korea.

Cho SH, Suh C, Do YR, Lee JJ, Yun HJ, Oh SY, Lee HS, Cho SG, Cho IS, Lee WS, Won YW, Kim HJ, Lee HG, Lee SI, Lim SN, Sohn BS, Ahn HJ, Chang MH, Kwon KA, Kim WS.

Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):197-202. doi: 10.1016/j.clml.2015.12.012. Epub 2016 Jan 6.

PMID:
26850215
34.

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.

Kim JS, Yoon DH, Park S, Yoon SS, Cho SG, Min CK, Lee JJ, Yang DH, Kwak JY, Eom HS, Kim WS, Kim H, Do YR, Moon JH, Lee J, Suh C.

Ann Hematol. 2016 Mar;95(4):603-11. doi: 10.1007/s00277-016-2589-y. Epub 2016 Jan 11.

PMID:
26754633
35.

A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.

Jeong SH, Kim YJ, Lee JH, Kim YK, Kim SJ, Park SK, Do YR, Kim I, Mun YC, Kim HG, Lee WS, Yi HG, Joo YD, Choi CW, Kim SR, Na SM, Jang JH.

Oncotarget. 2015 Dec 29;6(42):44985-94. doi: 10.18632/oncotarget.6242.

36.

Improved performance of dye-sensitized solar cells using dual-function TiO(2) nanowire photoelectrode.

Akbar ZA, Oh JH, Hadmojo WT, Yang SJ, Do YR, Jang SY.

Opt Express. 2015 Sep 21;23(19):A1280-7. doi: 10.1364/OE.23.0A1280.

PMID:
26406757
37.

Analysis of wide color gamut of green/red bilayered freestanding phosphor film-capped white LEDs for LCD backlight.

Oh JH, Kang H, Ko M, Do YR.

Opt Express. 2015 Jul 27;23(15):A791-804. doi: 10.1364/OE.23.00A791.

PMID:
26367681
38.

The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea.

Kim C, Lee HS, Min CK, Lee JJ, Kim K, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC.

Korean J Intern Med. 2015 Sep;30(5):675-83. doi: 10.3904/kjim.2015.30.5.675. Epub 2015 Aug 28.

39.

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.

Koh MS, Kim WS, Kim SJ, Oh SY, Yoon DH, Lee SI, Hong J, Song MK, Shin HJ, Kwon JH, Kim HJ, Do YR, Suh C, Kim HJ.

Int J Hematol. 2015 Oct;102(4):420-5. doi: 10.1007/s12185-015-1845-6. Epub 2015 Jul 26.

PMID:
26210384
40.

Analysis of circadian properties and healthy levels of blue light from smartphones at night.

Oh JH, Yoo H, Park HK, Do YR.

Sci Rep. 2015 Jun 18;5:11325. doi: 10.1038/srep11325.

41.

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients.

Park JS, Lee SE, Jeong SH, Jang EJ, Choi MY, Kim HJ, Kim YK, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Lee WS, Chang MH, Park J, Kwon JH, Kim DW.

Leuk Lymphoma. 2015 Jun 12:1-7. [Epub ahead of print]

PMID:
25947037
42.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.

Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, Kim HJ, Chae YS, Moon JH, Sohn SK, Lee SW, Byun BH, Do YR, Lee JJ, Yang DH.

BMC Cancer. 2015 Mar 28;15:198. doi: 10.1186/s12885-015-1193-1.

43.

Synthesis and characterization of green Zn-Ag-In-S and red Zn-Cu-In-S quantum dots for ultrahigh color quality of down-converted white LEDs.

Yoon HC, Oh JH, Ko M, Yoo H, Do YR.

ACS Appl Mater Interfaces. 2015 Apr 8;7(13):7342-50. doi: 10.1021/acsami.5b00664. Epub 2015 Mar 24.

PMID:
25781889
44.

Fabrication of a white electroluminescent device based on bilayered yellow and blue quantum dots.

Kim JH, Lee KH, Kang HD, Park B, Hwang JY, Jang HS, Do YR, Yang H.

Nanoscale. 2015 Mar 12;7(12):5363-70. doi: 10.1039/c5nr00426h.

PMID:
25721494
45.

Hybrid 2D photonic crystal-assisted Lu3Al5O12:Ce ceramic-plate phosphor and free-standing red film phosphor for white LEDs with high color-rendering index.

Park HK, Oh JH, Kang H, Zhang J, Do YR.

ACS Appl Mater Interfaces. 2015 Mar 4;7(8):4549-59. doi: 10.1021/am507237n. Epub 2015 Feb 23.

PMID:
25675264
46.

Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.

Hong J, Kim SJ, Ahn JS, Song MK, Kim YR, Lee HS, Yhim HY, Yoon DH, Kim MK, Oh SY, Park Y, Mun YC, Do YR, Ryoo HM, Lee JJ, Lee JH, Kim WS, Suh C.

Cancer Res Treat. 2015 Apr;47(2):173-81. doi: 10.4143/crt.2014.055. Epub 2014 Oct 28.

47.

Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL).

Jung SH, Lee JJ, Kim WS, Lee WS, Do YR, Oh SY, Kim MK, Mun YC, Shin HJ, Kwak JY, Kang HJ, Won JH, Kwon JH, Park E, Suh C, Yang DH.

Eur J Haematol. 2015 Jun;94(6):504-10. doi: 10.1111/ejh.12459. Epub 2014 Nov 21.

PMID:
25288018
48.

Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality.

Fuji S, Mori T, Khattry N, Cheng J, Do YR, Yakushijin K, Kohashi S, Fukuda T, Kim SW.

Bone Marrow Transplant. 2015 Jan;50(1):100-5. doi: 10.1038/bmt.2014.228. Epub 2014 Oct 6.

PMID:
25285803
49.

Changes in health-related quality of life and quality of care among terminally ill cancer patients and survival prediction: Multicenter prospective cohort study.

Lee MK, Lee WJ, Do YR, Lee KS, Jung KH, Heo DS, Kim SY, Park SY, Jeong HS, Kang JH, Kim SY, Park SR, Yun YH.

Palliat Support Care. 2015 Aug;13(4):1103-11. doi: 10.1017/S1478951514000960. Epub 2014 Sep 5.

PMID:
25192193
50.

Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.

Lee GW, Go SI, Kim SH, Hong J, Kim YR, Oh S, Kim SY, Do YR, Lee H, Lee SI, Bae SH, Oh SY, Song MK, Lee WS, Lee B, Kim JS, Kim MK, Kang HJ, Ahn JS, Yhim HY, Kim HJ, Kim SJ, Kim WS, Suh C; Consortium for Improving Survival of Lymphoma (CISL) study group.

Leuk Lymphoma. 2015 Apr;56(4):1020-6. doi: 10.3109/10428194.2014.946027. Epub 2014 Aug 20.

PMID:
25039351

Supplemental Content

Support Center